Wytwarzanie produktów leczniczych jest dla nas nie tylko kwestia wykonania pewnego procesu technologicznego, ale misją związaną z człowiekiem opartą na wysokim standardzie jakości, bezpieczeństwa i skuteczności leków.
Mamy aktywną i kluczową rolę w podnoszeniu standardów życia codziennego. Sprawiamy, że społeczeństwo jest lepiej poinformowane, zdrowsze, szczęśliwsze i bezpieczniejsze
Sofia, Bulgaria, September 3, 2025 – According to the requirements of art. 17 of the Regulation (EU) No 596/2014 of the European Parliament and of the Council, “Sopharma” AD (SFA: Bulgarian Stock Exchange, SPH: Warsaw Stock Exchange) notifies that on September 2, 2025 the Company sold 9 890 (nine thousand eight hundred and ninety) treasury shares representing 0.002% of the share capital of the Company, at a total value of BGN 26 542.10 on the Bulgarian Stock Exchange, the average price per share was BGN 2.68.
Sofia, Bulgaria, September 2, 2025 – According to the requirements of art. 17 of the Regulation (EU) No 596/2014 of the European Parliament and of the Council, “Sopharma” AD (SFA: Bulgarian Stock Exchange, SPH: Warsaw Stock Exchange) notifies that on September 1, 2025 the Company sold 56 195 (fifty-six thousand one hundred and ninety-five) treasury shares representing 0.01% of the share capital of the Company, at a total value of BGN 148 544.50 on the Bulgarian Stock Exchange, the average price per share was BGN 2.64.
Sofia, Bulgaria, September 1, 2025 – According to the requirements of art. 17 of the Regulation (EU) No 596/2014 of the European Parliament and of the Council, “Sopharma” AD (SFA: Bulgarian Stock Exchange, SPH: Warsaw Stock Exchange) notifies that on August 29, 2025 the Company sold 94 677 (ninety-four thousand and six hundred seventy-seven) treasury shares representing 0.02% of the share capital of the Company, at a total value of BGN 239 619.89 on the Bulgarian Stock Exchange, the average price per share was BGN 2.53.
Sofia, Bulgaria, August 29, 2025 – According to the requirements of art. 17 of the Regulation (EU) No 596/2014 of the European Parliament and of the Council, “Sopharma” AD (SFA: Bulgarian Stock Exchange, SPH: Warsaw Stock Exchange) notifies that on August 28, 2025 the Company sold 62 700 (sixty-two thousand and seven hundred) treasury shares representing 0.01% of the share capital of the Company, at a total value of BGN 156 660.00 on the Bulgarian Stock Exchange, the average price per share was BGN 2.50.
